N (%) | |
---|---|
Age at visit, years (median, IQR) | 11.6 (7.2, 15.5) |
Disease duration, years (median, IQR) | 2.8 (1.2, 5.5) |
Male | 43 (27) |
Race | |
White | 132 (82) |
Black | 12 (8) |
Asian | 5 (3) |
Pacific Islander | 2 (1) |
More than 1 race | 1 (1) |
Other | 7 (4) |
Unknown | 2 (1) |
ILAR category | |
Systemic | 14 (9) |
Oligoarticular, persistent | 44 (27) |
Oligoarticular, extended | 12 (7) |
Polyarticular, RF-negative | 36 (22) |
Polyarticular, RF-positive | 4 (3) |
PsA | 14 (9) |
ERA | 22 (14) |
Undifferentiated | 15 (9) |
Physician disease activity VAS (median, IQR) | 0 (0,1) |
Physician-defined status | |
Active disease | 43 (27) |
Inactive disease, on medication < 6 months | 26 (16) |
Clinical remission while on medication | 53 (34) |
Clinical remission, off medication <12 months | 17 (11) |
Clinical remission, off medication >12 months | 19 (12) |
Subject/parent global health status VAS | 1 (0, 3) |
Subject/parent pain VAS | 1 (0, 4) |